Representative Matters

Mergers & Acquisitions Transactions

Mr. Weiss provided representation to:

  • the senior management team of a New York-based pharmaceutical marketing company regarding the rollover of their equity, employment agreements, and related matters in connection with the sale of the company by one private equity sponsor to another private equity sponsor
  • the senior management team of a consumer brands company regarding the rollover of their equity, employment agreements, and related matters in connection with the sale of the company by one private equity sponsor to another private equity sponsor
  • the executive management team of an investment firm in connection with their management buyout of the firm from its direct and indirect parent companies
  • a home care company in its acquisition of another private equity-backed home health care company
  • a private equity-backed national wound care management services company in its acquisition of a regional wound care management services company
  • a venture-backed health care staffing company in its sale to a private equity-backed purchaser
  • a publicly-held software and services provider in its merger with and into another software and services provider
  • a New York-based accounting firm in connection with its merger with a multinational accounting firm
  • a national private-equity backed for-profit hospital system in connection with its acquisition of four distinct hospital systems in Connecticut, New Jersey, and Rhode Island
  • a privately held pharmaceutical company in connection with its sale of a product line to a specialty pharmaceutical company
  • a health care accounts receivables management company in its sale to a private equity-backed strategic purchaser
  • an NYSE-listed pharmaceutical company in its sale of certain of its Egyptian plant and operations to another major pharmaceutical company
  • an NYSE-listed medical device manufacturer in its sale to a Fortune 25 health care company
  • a multi-hospital nonprofit system in connection with its acquisition of another nonprofit hospital
  • a community hospital in connection with its sale to a large multi-hospital system
  • a private clinical trial materials company in its sale to a private equity-backed strategic purchaser
  • a receivables and loan collections company in connection with an investment by a financial sponsor
  • an apparel company in its acquisition of a retail clothing chain with stores throughout the United States
  • an Irish private equity sponsor in its purchase of an international provider of temporary corporate housing from a NYSE-listed seller
  • an Australian, publicly held biotechnology company in its sale of assets related to two product lines to a U.S.-based purchaser
  • a Spanish-based renewable energy company in its purchase of an equity stake in a U.S.-based company
  • a private market research firm in its sale to a German-based strategic purchaser
  • an education and training business in its sale to a Nasdaq National Market-listed strategic purchaser
  • a public software and services provider in its purchase of a software development and IT consulting firm and its purchase of a software development company
  • a private equity sponsor in its purchase of a Georgia-based manufacturing and processing company
  • a private equity-backed metal-part fabricator in its purchase of a Wisconsin-based metal fabricator
  • an NYC-based hospital, home health care program and skilled nursing facility in a Section 363 sale of its assets in bankruptcy

Public Company/SEC

Mr. Weiss represented the following entities:

  • an NYSE Amex-listed health and wellness and risk assessment services company
  • a Nasdaq Global Market-listed medical device manufacturer
  • an NYSE Amex-listed software and services provider
  • an NYSE-listed medical device manufacturer
  • an AMEX-listed mortgage REIT

Capital Markets/Securities Transactions

Mr. Weiss provided representation to:

  • the lead underwriter in the $55.2 million follow-on common stock offering of Somanetics Corporation, a medical device company that develops and manufactures non-invasive patient oximetric monitoring systems
  • an NYSE-listed medical device manufacturer in its comprehensive $550 million recapitalization, which involved simultaneous common stock and high-yield debt offerings, establishment of a new bank credit facility, tender offers for three outstanding series of high-yield debt, and a merger
  • the lead underwriter in the $85 million follow-on common stock offering of Intuitive Surgical, Inc., a medical device company that manufactures robotic surgical systems
  • a global offshore software development company in its $50 million private placement of preferred stock
  • a mortgage REIT in its $34.5 million follow-on offering of common stock
  • a mortgage REIT in its $20 million private placement of trust preferred securities
  • an investment bank, as lead underwriter, in connection with a BDC issuer, as candidate for an initial public offering
  • a private equity/VC investor group in connection with the acquisition of preferred stock in a marketing program provider